Pacira BioSciences, Inc.

NasdaqGS:PCRX Stok Raporu

Piyasa değeri: US$786.3m

Pacira BioSciences Yönetim

Yönetim kriter kontrolleri 2/4

Pacira BioSciences CEO'su Frank Lee, Jan2024 tarihinde atandı, in görev süresi bir yıldan az. şirketin hisselerinin 0.018% doğrudan sahiptir ve bu hisselerin değeri $ 140.75K dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.5 yıl ve 5.2 yıldır.

Anahtar bilgiler

Frank Lee

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresiless than a year
CEO sahipliği0.02%
Yönetim ortalama görev süresi2.5yrs
Yönetim Kurulu ortalama görev süresi5.2yrs

Son yönetim güncellemeleri

Recent updates

Pacira BioSciences, Inc. (NASDAQ:PCRX) Not Doing Enough For Some Investors As Its Shares Slump 34%

Sep 06
Pacira BioSciences, Inc. (NASDAQ:PCRX) Not Doing Enough For Some Investors As Its Shares Slump 34%

Little Excitement Around Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Revenues As Shares Take 29% Pounding

Jul 23
Little Excitement Around Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Revenues As Shares Take 29% Pounding

These 4 Measures Indicate That Pacira BioSciences (NASDAQ:PCRX) Is Using Debt Safely

Jun 07
These 4 Measures Indicate That Pacira BioSciences (NASDAQ:PCRX) Is Using Debt Safely

Pacira BioSciences, Inc. Just Missed Earnings - But Analysts Have Updated Their Models

May 10
Pacira BioSciences, Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Getting In Cheap On Pacira BioSciences, Inc. (NASDAQ:PCRX) Might Be Difficult

May 03
Getting In Cheap On Pacira BioSciences, Inc. (NASDAQ:PCRX) Might Be Difficult

Does Pacira BioSciences (NASDAQ:PCRX) Have A Healthy Balance Sheet?

Feb 05
Does Pacira BioSciences (NASDAQ:PCRX) Have A Healthy Balance Sheet?

Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Low P/S No Reason For Excitement

Jan 05
Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Low P/S No Reason For Excitement

We Think Pacira BioSciences (NASDAQ:PCRX) Can Stay On Top Of Its Debt

Nov 03
We Think Pacira BioSciences (NASDAQ:PCRX) Can Stay On Top Of Its Debt

Is Pacira BioSciences (NASDAQ:PCRX) Using Too Much Debt?

Jul 28
Is Pacira BioSciences (NASDAQ:PCRX) Using Too Much Debt?

Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Intrinsic Value Is Potentially 26% Below Its Share Price

Jul 07
Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Intrinsic Value Is Potentially 26% Below Its Share Price

Is Pacira BioSciences (NASDAQ:PCRX) A Risky Investment?

Apr 18
Is Pacira BioSciences (NASDAQ:PCRX) A Risky Investment?

We Think Pacira BioSciences (NASDAQ:PCRX) Can Stay On Top Of Its Debt

Dec 28
We Think Pacira BioSciences (NASDAQ:PCRX) Can Stay On Top Of Its Debt

Assessing Pacira BioSciences' Growth Prospects

Oct 20

Pacira BioSciences guides Q3 revenue below consensus

Oct 13

Pacira, Sevāredent team up to expand access to pain drug Exparel for dental procedures

Sep 27

EMA panel backs expanding indication for Pacira's postsurgical pain treatment in kids

Sep 20

Pacira BioSciences records 17.7% sequential growth in August revenue

Sep 13

Pacira BioSciences provides update on July product sales

Aug 10

Pacira BioSciences Q2 2022 Earnings Preview

Aug 02

Pacira BioSciences sees Q2 revenue below consensus

Jul 14

CEO

Frank Lee (56 yo)

less than a year

Görev süresi

Mr. Frank D. Lee served as an Independent Director at Bolt Biotherapeutics, Inc. since November 2021 until September 2024. He is Independent Director of Bausch Health Companies Inc. from May 14, 2024. He i...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Daryl Gaugler
Chief Operating Officer2.5yrsUS$1.53m0.027%
$ 208.6k
Kristen Williams
Chief Administrative Officer & Secretary10.1yrsUS$1.60m0%
$ 0
David Stack
Advisorless than a yearUS$6.88m0.51%
$ 4.0m
Charles Reinhart
Executive Officerless than a yearUS$1.43m0.059%
$ 467.0k
Jonathan Slonin
Chief Medical Officer3.3yrsUS$1.59m0.028%
$ 221.0k
Frank Lee
CEO & Directorless than a yearVeri yok0.018%
$ 140.8k
Shawn Cross
Chief Financial Officerless than a yearVeri yokVeri yok
Lauren Riker
Principal Accounting Officer & Senior VP of Finance12.7yrsUS$288.82k0.0046%
$ 36.4k
Susan Mesco
Head of Investor Relationsno dataVeri yokVeri yok
Anthony Molloy
Chief Legal & Compliance Officer2.9yrsUS$2.05m0.028%
$ 219.3k
Richard Kahr
Vice President of Human Resources9.3yrsVeri yokVeri yok
Christopher Young
Chief Manufacturing Officer1.6yrsVeri yokVeri yok

2.5yrs

Ortalama Görev Süresi

54yo

Ortalama Yaş

Deneyimli Yönetim: PCRX 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.5 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Frank Lee
CEO & Directorless than a yearVeri yok0.018%
$ 140.8k
Laura Brege
Independent Director13.4yrsUS$364.01k0.027%
$ 209.9k
Paul Hastings
Chairman of the Board13.4yrsUS$390.51k0.016%
$ 127.6k
Andreas Wicki
Independent Director17.9yrsVeri yokVeri yok
Mark Kronenfeld
Independent Director11.4yrsUS$373.01k0.043%
$ 335.0k
Christopher Christie
Independent Director5.2yrsUS$325.01k0.011%
$ 89.6k
Alethia Young
Independent Director1.1yrsUS$427.86k0%
$ 0
Marcelo Bigal
Independent Director1.1yrsUS$426.45k0.011%
$ 83.7k
Abraham Ceesay
Independent Director1.1yrsUS$427.16k0%
$ 0
Mark Froimson
Independent Director7.4yrsUS$349.01k0.020%
$ 157.4k
Michael Yang
Independent Director1.1yrsUS$427.16k0.0043%
$ 34.0k

5.2yrs

Ortalama Görev Süresi

62.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: PCRX 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.2 yıldır).